IP Library › Granted Patent US 12,288,125
Granted Patent B2
US 12,288,125 · App. 18/651,204 · Granted Apr 29, 2025

Component arrangement for an x-ray therapy component, x-ray therapy system, and method for operating an x-ray therapy system

Inventor: Frank Weigand (Heidenheim, DE)
Assignee: Carl Zeiss Meditec AG
G06K7/10475A61N5/1048A61N5/1083
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,288,125
App. No.
18/651,204
Granted
Apr 29, 2025
Kind
B2
Abstract

A component arrangement includes an x-ray therapy component having a first RFID transponder, a primary packaging, in which the component is sterilely packed, and secondary packaging with a second RFID transponder in which the component packed in the primary packaging is arranged. An x-ray therapy system and a method for operating an x-ray therapy system are provided, in which data of a second RFID transponder arranged in and/or on secondary packaging of the component are read with a second RFID reader of a control device of the x-ray therapy system, and/or data are written to the second RFID transponder, the component sterilely packed in primary packaging is removed from the primary packaging, and data of a first RFID transponder of the component are read with a first RFID reader of an x-ray therapy device of the x-ray therapy system, and/or data are written to the first RFID transponder.

Claims (30)

1. A component arrangement for an x-ray therapy component, comprising:

an x-ray therapy component which has a first RFID transponder;

a primary packaging in which the x-ray therapy component is packaged sterilely;

a secondary packaging in which the x-ray therapy component packaged in the primary packaging is arranged; and

a second RFID transponder arranged in and/or on the secondary packaging.

2. The component arrangement as claimed in claim 1 , wherein at least one of (1) the first RFID transponder and (2) the second RFID transponder are configured to provide unique component identification data.

3. The component arrangement as claimed in claim 1 , wherein the first RFID transponder is biocompatible.

4. The component arrangement as claimed in claim 1 , wherein the first RFID transponder is sterilizable with a sterilization method.

5. The component arrangement as claimed in claim 1 , wherein the x-ray therapy component is an applicator for x-ray therapy.

6. An x-ray therapy system, comprising:

an x-ray therapy device having a holding device configured to at least one of (1) hold and (2) position at least one x-ray therapy component of the component arrangement as claimed in claim 1 in and/or on a patient;

an operating device configured to control the x-ray therapy device,

wherein the x-ray therapy device includes at least one first RFID reader configured to at least one of (1) read-out data from the first RFID transponder arranged on or in the at least one x-ray therapy component of the component arrangement and (2) write data to the first RFID transponder,

wherein the operating device includes at least one second RFID reader configured to at least one of (1) read-out data from the second RFID transponder arranged in and/or on the secondary packaging of the component arrangement and (2) write data to said second RFID transponder, and

wherein the x-ray therapy system is configured, for each of at least one x-ray therapy component, to:

utilize a second RFID reader of an operating device of the x-ray therapy system to at least one of (1) read data from a second RFID transponder arranged in and/or on a secondary packaging of the at least one x-ray therapy component and (2) write data to the second RFID transponder,

take the at least one x-ray therapy component sterilely packaged in a primary packaging from the primary packaging, and

utilize a first RFID reader of an x-ray therapy device of the x-ray therapy system to at least one of (1) read data from a first RFID transponder of the at least one x-ray therapy component and (2) write data to the first RFID transponder.

7. The x-ray therapy system as claimed in claim 6 , wherein the at least one first RFID reader is arranged on the holding device in a connection region in which the at least one x-ray therapy component is arranged or can be arranged on the holding device.

8. A method for operating an x-ray therapy system, the method comprising:

configuring the x-ray therapy system for each of at least one x-ray therapy component present in the component arrangement as claimed in claim 1 by:

utilizing a second RFID reader of an operating device of the x-ray therapy system to at least one of (1) read data from a second RFID transponder arranged in and/or on a secondary packaging of the at least one x-ray therapy component and (2) write data to the second RFID transponder;

taking the at least one x-ray therapy component sterilely packaged in a primary packaging from the primary packaging; and

utilizing a first RFID reader of an x-ray therapy device of the x-ray therapy system to at least one of (1) read data from a first RFID transponder of the at least one x-ray therapy component and (2) write data to the first RFID transponder.

9. The method as claimed in claim 8 , further comprising:

giving clearance to an x-ray therapy if the data from the first RFID transponder of the at least one x-ray therapy component include at least one piece of specified information.

10. The method as claimed in claim 8 , wherein a use of the at least one x-ray therapy component is followed by storing a piece of information in the first RFID transponder, and

wherein the information at least one of (1) marks the at least one x-ray therapy component as used and (2) includes a number of uses of the at least one x-ray therapy component.

11. The method as claimed in claim 8 , wherein the first RFID transponder is rendered unusable after use and/or once a given number of uses have been reached.

12. The method as claimed in claim 8 , wherein the at least one x-ray therapy component is sterilized after one use.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2024
From: WEIGAND, FRANK
To: CARL ZEISS MEDITEC AG
Reel/Frame 069660/0348 →
Priority Claims (1)
DE 10 2021 212 808.4 · Nov 15, 2021 · national
Continuity (2)
Continuation PCTEP2022081833 · Nov 14, 2022
Related Publication 20240281627A1 · Aug 22, 2024
References Cited (23)
US 20080296373A1 · Zmood et al. · 2008 [cited by applicant]
US 20090102612A1 · Dalbow et al. · 2009 [cited by applicant]
US 20140125482A1 · Rigsby et al. · 2014 [cited by applicant]
US 20140251845A1 · Roesler · 2014 [cited by applicant]
US 20160048712A1 · Butler et al. · 2016 [cited by applicant]
US 20160287901A1 · Dumaine et al. · 2016 [cited by applicant]
US 20190290392A1 · Hansen et al. · 2019 [cited by applicant]
US 20210084700A1 · Daniels · 2021 [cited by applicant]
US 20210299468A1 · Symalla et al. · 2021 [cited by applicant]
CN 109561942A · 2019 [cited by applicant]
CN 113440737A · 2021 [cited by applicant]
DE 10352556A1 · 2005 [cited by applicant]
DE 102013004168A1 · 2014 [cited by applicant]
DE 102020104628B3 · 2021 [cited by applicant]
EP 3868441B1 · 2022 [cited by applicant]
WO 2009052048A1 · 2009 [cited by applicant]
WO 2014071337A1 · 2014 [cited by applicant]
WO 2015066814A1 · 2015 [cited by applicant]
International Preliminary Report on Patentability dated Oct. 4, 2023, of international patent application PCT/EP2022/081833 on which this application is based, and English language translation thereof. [cited by applicant]
International Search Report and Written Opinion dated Feb. 17, 2023, of international patent application PCT/EP2022/081833 on which this application is based, and English language translation thereof. [cited by applicant]
Office Action dated Jul. 25, 2024 issued in Chinese counterpart application No. 202280071915.4, and English language translation thereof. [cited by applicant]
Chinese Search Report dated Jul. 23, 2024, of the Chinese counterpart application No. 202280071915.4, and English language translation thereof. [cited by applicant]
Chinese Office Action and Search Report dated Jan. 17, 2025, of the Chinese counterpart application No. 202280071915.4, and English language translation thereof. [cited by applicant]